+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Persistant Allergic Rhinitis Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4768057
  • Report
  • April 2019
  • Region: Global
  • 40 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Crescita Therapeutics Inc
  • DCC Healthcare Ltd
  • Eurofarma Laboratorios SA
  • GlaxoSmithKline Plc
  • Grupo NC
  • J Uriach Y Compania SA
  • MORE
The global clinical trial report- “2019 Persistant Allergic Rhinitis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Persistant Allergic Rhinitis. It presents in-depth analysis of Persistant Allergic Rhinitis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Persistant Allergic Rhinitis.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Persistant Allergic Rhinitis clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Persistant Allergic Rhinitis

The research work is prepared through extensive and continuous research on Persistant Allergic Rhinitis trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Persistant Allergic Rhinitis patients are identified
  • The report includes panorama of Persistant Allergic Rhinitis clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Persistant Allergic Rhinitis clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Crescita Therapeutics Inc
  • DCC Healthcare Ltd
  • Eurofarma Laboratorios SA
  • GlaxoSmithKline Plc
  • Grupo NC
  • J Uriach Y Compania SA
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Persistant Allergic Rhinitis Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Persistant Allergic Rhinitis Clinical Trials by Region
2.2.2 Average Enrollment of Persistant Allergic Rhinitis Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Persistant Allergic Rhinitis Treatment, 2019

3. Region wise Persistant Allergic Rhinitis Clinical Trials
3.1 Asia Pacific Persistant Allergic Rhinitis Clinical Trials by Country
3.2 Europe Persistant Allergic Rhinitis Clinical Trials by Country
3.3 North America Persistant Allergic Rhinitis Clinical Trials by Country
3.4 Middle East and Africa Persistant Allergic Rhinitis Clinical Trials by Country
3.5 South and Central America Persistant Allergic Rhinitis Clinical Trials by Country

4. Persistant Allergic Rhinitis Clinical Trial Trends
4.1 Start Year wise Persistant Allergic Rhinitis Clinical Trials
4.2 Phase wise Persistant Allergic Rhinitis Clinical Trials
4.3 Trial Status wise Persistant Allergic Rhinitis Clinical Trials
4.4 Trial Type wise Persistant Allergic Rhinitis Clinical Trials

5. Persistant Allergic Rhinitis Average Enrollment Trends
5.1 Average Enrollment in Persistant Allergic Rhinitis Trials by Year
5.2 Average Enrollment in Persistant Allergic Rhinitis Trials by Phase
5.3 Average Enrollment in Persistant Allergic Rhinitis Trials by Status
5.4 Average Enrollment in Persistant Allergic Rhinitis Trials by Type of Trial

6. Companies Participating in Persistant Allergic Rhinitis Clinical Trials
6.1 Persistant Allergic Rhinitis Trials by Sponsor Type
6.2 Persistant Allergic Rhinitis Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Persistant Allergic Rhinitis Trials- Phase 1
7.2 Persistant Allergic Rhinitis Trials- Phase 2
7.3 Persistant Allergic Rhinitis Trials- Phase 3
7.4 Persistant Allergic Rhinitis Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Persistant Allergic Rhinitis Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Figure 5: Europe - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Figure 7: North America - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Figure 9: Persistant Allergic Rhinitis Clinical Trials by Phase
Figure 10: Persistant Allergic Rhinitis Clinical Trials by Trial Status
Figure 11: Persistant Allergic Rhinitis Clinical Trials by Type
Figure 12: Persistant Allergic Rhinitis Clinical Trials by Sponsor Type
Figure 13: Persistant Allergic Rhinitis Clinical Trials by Leading Sponsors
Figure 14: Persistant Allergic Rhinitis Average Enrollment by Phase
Figure 15: Persistant Allergic Rhinitis Average Enrollment by Trial Status
Figure 16: Persistant Allergic Rhinitis Average Enrollment by Type
Figure 17: Persistant Allergic Rhinitis- Average Enrolment by Type of Sponsors
Figure 18: Persistant Allergic Rhinitis- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Persistant Allergic Rhinitis Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Table 5: Europe - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Table 7: North America - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Persistant Allergic Rhinitis Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Persistant Allergic Rhinitis Average Enrollment by Phase
Table 15: Persistant Allergic Rhinitis Average Enrollment by Trial Status
Table 16: Persistant Allergic Rhinitis Average Enrollment by Type
Table 17: Persistant Allergic Rhinitis- Average Enrolment by Type of Sponsors
Table 18: Persistant Allergic Rhinitis- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3
  • UCB SA
  • Crescita Therapeutics Inc
  • DCC Healthcare Ltd
  • Eurofarma Laboratorios SA
  • GlaxoSmithKline Plc
  • Grupo NC
  • J Uriach Y Compania SA
  • Novartis AG
  • Nuvo Pharmaceuticals Inc
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll